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Background
We recently reported that mutation of the cGMP-depen-
dent Protein Kinase G I alpha (PKGIa) N-terminal leucine
zipper (LZ) domain (in the PKGIa LZ mutant, or LZM,
mouse) accelerates cardiac remodeling and heart failure
after left ventricular (LV) pressure overload, and prevents
the anti-remodeling effect of sildenafil [1]. We therefore
hypothesized that PKGIa attenuates remodeling by regu-
lating cardiac signaling pathways that are dependent on
substrate interactions mediated by its LZ domain. As a
first step to identifying cardiac proteins downstream of
PKGIa, we screened myocardial lysates for PKGIa LZ
domain-interacting proteins. Our previous work revealed a
requirement for the PKGIa LZ domain for the activation
of anti-remodeling myocardial JNK activity after LV pres-
sure overload. MLK3 is a MAPKKK that contains an LZ
domain and activates JNK.
Results
We now demonstrate, by immunoprecipitation, that MLK
3 interacts with the PKGIa LZ domain in myocardial
lysates. We show further that 8-Br-cGMP induces MLK3
phosphorylation on Thr277 and Ser281 in WT, but not
LZM lysates. And, in 293 cells transfected with FLAG-
MLK3, 8Br-cGMP induced PKGIa-MLK3 co-precipitation,
and increased MLK3 phosphorylation on Thr277/Ser281.
Co-transfection of MLK3 and PKGIa also induced MLK3
phosphorylation. We next examined the cardiovascular
effect of MLK3 deletion in vivo. Male 8 week old MLK3-/-
mice display basal bi-ventricular hypertrophy compared
with littermate controls (LV/Tibia length 42.8 ± 0.6 mg/cm
in WT, 52.9 ± 1.8 in MLK3 -/-; P<0.01; RV/TL 10.8 ± 0.1
mg/cm in WT, 13.3 ± 0.3 in MLK3-/-; P<0.01; n= 7 WT,
5 MLK3-/-). By 14-16 weeks of age, LVH progressed in the
MLK3-/- mice (LV/TL 47.7 ± 1.3 mg/cm in WT, 59.8 ±
7.5 in MLK3-/-; n= 6 WT, 9 MLK3-.-; P<0.01). Arterial
blood pressure was modestly increased, though still nor-
mal, in MLK3-/- mice (SBP 93 ± 1 in WT, 113 ± 1 in
MLK3-/-). And, 14-16 week MLK3-/- mice have impaired
LV diastolic function (tau 3.2 ± 0.1 ms WT, 3.7 ± 0.1
MLK3-/-; P 0.06).
Conclusion
Our studies reveal a novel function of MLK3 as a myocar-
dial PKGIa effector and inhibitor of LVH. These results
support the strategy of exploring LZ-dependent PKGIa
substrates in the myocardium to identify potential thera-
peutic targets for cardiac remodeling.
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